Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $42,325 | 18 | 74.7% |
| Travel and Lodging | $7,945 | 26 | 14.0% |
| Compensation for serving as faculty or as a speaker for a medical education program | $4,500 | 1 | 7.9% |
| Food and Beverage | $1,873 | 31 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $10,693 | 13 | $0 (2021) |
| Janssen Biotech, Inc. | $6,603 | 9 | $0 (2019) |
| Dexcom, Inc. | $5,458 | 6 | $0 (2024) |
| F. Hoffmann-La Roche AG | $4,469 | 4 | $0 (2018) |
| LEO Pharma Inc. | $4,275 | 1 | $0 (2020) |
| PFIZER INC. | $4,269 | 6 | $0 (2019) |
| Allergan, Inc. | $4,226 | 10 | $0 (2020) |
| Genentech, Inc. | $4,129 | 7 | $0 (2022) |
| Shionogi Inc | $3,636 | 5 | $0 (2017) |
| Novo Nordisk Inc | $2,910 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,259 | 9 | Dexcom, Inc. ($5,458) |
| 2023 | $1,110 | 2 | Novo Nordisk Inc ($1,110) |
| 2022 | $3,150 | 2 | Novo Nordisk Inc ($1,800) |
| 2021 | $5,660 | 10 | Genentech USA, Inc. ($4,508) |
| 2020 | $17,659 | 20 | Genentech USA, Inc. ($6,185) |
| 2019 | $13,689 | 23 | Janssen Biotech, Inc. ($6,603) |
| 2018 | $4,480 | 5 | F. Hoffmann-La Roche AG ($4,469) |
| 2017 | $3,636 | 5 | Shionogi Inc ($3,636) |
All Payment Transactions
76 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/13/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $31.52 | General |
| 09/13/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $19.50 | General |
| 08/21/2024 | Lundbeck LLC | VYEPTI (Biological) | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| Category: NEUROLOGY | ||||||
| 04/03/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $4,500.00 | General |
| Category: Endocrinology | ||||||
| 04/03/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Travel and Lodging | Cash or cash equivalent | $127.34 | General |
| Category: Endocrinology | ||||||
| 02/23/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Travel and Lodging | In-kind items and services | $249.00 | General |
| Category: Endocrinology | ||||||
| 02/23/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Travel and Lodging | In-kind items and services | $28.60 | General |
| Category: Endocrinology | ||||||
| 02/22/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Travel and Lodging | In-kind items and services | $515.69 | General |
| Category: Endocrinology | ||||||
| 02/22/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Travel and Lodging | In-kind items and services | $37.54 | General |
| Category: Endocrinology | ||||||
| 05/24/2023 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $740.00 | General |
| 05/23/2023 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $370.00 | General |
| 09/12/2022 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| 01/21/2022 | Genentech, Inc. | Xolair (Biological) | Consulting Fee | Cash or cash equivalent | $1,350.00 | General |
| Category: Immunology | ||||||
| 11/09/2021 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Consulting Fee | Cash or cash equivalent | $1,095.00 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2021 | Genentech USA, Inc. | HEMLIBRA (Biological) | Food and Beverage | In-kind items and services | $228.48 | General |
| Category: Hematology | ||||||
| 10/21/2021 | Genentech USA, Inc. | HEMLIBRA (Biological) | Consulting Fee | Cash or cash equivalent | $3,325.00 | General |
| Category: Hematology | ||||||
| 10/21/2021 | Genentech USA, Inc. | HEMLIBRA (Biological) | Travel and Lodging | In-kind items and services | $624.97 | General |
| Category: Hematology | ||||||
| 10/21/2021 | Genentech USA, Inc. | HEMLIBRA (Biological) | Travel and Lodging | In-kind items and services | $162.56 | General |
| Category: Hematology | ||||||
| 10/21/2021 | Genentech USA, Inc. | HEMLIBRA (Biological) | Travel and Lodging | Cash or cash equivalent | $128.70 | General |
| Category: Hematology | ||||||
| 10/21/2021 | Genentech USA, Inc. | HEMLIBRA (Biological) | Food and Beverage | Cash or cash equivalent | $38.27 | General |
| Category: Hematology | ||||||
| 06/04/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: NEUROSCIENCE | ||||||
| 03/31/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: NEUROSCIENCE | ||||||
| 01/08/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: NEUROSCIENCE | ||||||
| 09/02/2020 | Lilly USA, LLC | — | Consulting Fee | Cash or cash equivalent | $1,912.50 | General |
About Dr. Teresa Ramos, M.D
Dr. Teresa Ramos, M.D is a Internal Medicine healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376585877.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Teresa Ramos, M.D has received a total of $56,643 in payments from pharmaceutical and medical device companies, with $7,259 received in 2024. These payments were reported across 76 transactions from 16 companies. The most common payment nature is "Consulting Fee" ($42,325).
Practice Information
- Specialty Internal Medicine
- Location Chicago, IL
- Active Since 06/11/2006
- Last Updated 06/20/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1376585877
Products in Payments
- Non-Covered Product (Drug) $10,654
- Tremfya (Drug) $6,603
- DEXCOM G7 GSS (161) (Medical Supply) $5,458
- HEMLIBRA (Biological) $4,508
- ERAXIS (Drug) $3,112
- Activase (Biological) $2,779
- VYEPTI (Biological) $1,750
- Xolair (Biological) $1,350
- ZEJULA (Drug) $1,095
- VRAYLAR (Drug) $112.11
- Orilissa (Drug) $23.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Chicago
Dr. Myles Wolf, Md, MD
Internal Medicine — Payments: $1.8M
Dr. Merle Diamond, Md, MD
Internal Medicine — Payments: $1.4M
Dr. Elizabeth Kiracofe, M.d, M.D
Internal Medicine — Payments: $1.2M
Robert Kushner, Md, MD
Internal Medicine — Payments: $549,886
Dr. Adam Stein, M.d, M.D
Internal Medicine — Payments: $503,325
Devalingam Mahalingam, M.d, M.D
Internal Medicine — Payments: $501,247